Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Vericel Corproation (VCEL)

Vericel Corproation (VCEL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,741,986
  • Shares Outstanding, K 46,815
  • Annual Sales, $ 124,180 K
  • Annual Income, $ 3,040 K
  • 60-Month Beta 1.95
  • Price/Sales 14.07
  • Price/Cash Flow 304.57
  • Price/Book 11.14
Trade VCEL with:

Options Overview Details

View History
  • Implied Volatility 70.90%
  • Historical Volatility 56.71%
  • IV Percentile 90%
  • IV Rank 66.94%
  • IV High 84.27% on 05/13/21
  • IV Low 43.83% on 12/09/20
  • Put/Call Vol Ratio 0.00
  • Today's Volume 15
  • Volume Avg (30-Day) 256
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 2
  • Open Int (30-Day) 14

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/21
See More
  • Average Estimate 0.20
  • Number of Estimates 3
  • High Estimate 0.22
  • Low Estimate 0.17
  • Prior Year 0.25
  • Growth Rate Est. (year over year) -20.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
35.18 +0.06%
on 12/01/21
51.08 -31.09%
on 11/04/21
-10.64 (-23.21%)
since 11/01/21
3-Month
35.18 +0.06%
on 12/01/21
60.24 -41.57%
on 09/02/21
-21.28 (-37.68%)
since 09/01/21
52-Week
24.31 +44.80%
on 12/03/20
68.94 -48.94%
on 06/25/21
+9.38 (+36.33%)
since 12/01/20

Most Recent Stories

More News
Vericel to Present at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health and Services Forum on November 18th, 2021

CAMBRIDGE, Mass., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe...

VCEL : 35.20 (-5.40%)
Vericel Corporation (VCEL) Reports Q3 Loss, Misses Revenue Estimates

Vericel Corporation (VCEL) delivered earnings and revenue surprises of -266.67% and -11.12%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?...

VCEL : 35.20 (-5.40%)
Vericel Reports Third Quarter 2021 Financial Results

Third Quarter Total Net Revenue of $34.5 Million Year-To-Date 2021 Revenue Increased 38% to $108.6 Million Conference Call Today at 8:30am...

VCEL : 35.20 (-5.40%)
Earnings Preview: Vericel Corporation (VCEL) Q3 Earnings Expected to Decline

Vericel Corporation (VCEL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

VCEL : 35.20 (-5.40%)
Vericel to Report Third-Quarter 2021 Financial Results on November 9, 2021

CAMBRIDGE, Mass., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe...

VCEL : 35.20 (-5.40%)
Vericel to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference on September 13th, 2021

CAMBRIDGE, Mass., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick...

VCEL : 35.20 (-5.40%)
Vericel Expands Executive Leadership Team and Announces Appointment of Patrick Fowler as Senior Vice President, Corporate Development and Strategy

CAMBRIDGE, Mass., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, announced the appointment...

VCEL : 35.20 (-5.40%)
Vericel Reports Second Quarter 2021 Financial Results and Raises Full-Year 2021 Revenue Guidance

Second Quarter Total Net Revenue Increased 97% to $39.5 Million

VCEL : 35.20 (-5.40%)
Vericel Corporation Investors: Company Investigated by the Portnoy Law Firm

Investors can contact the law firm at no cost to learn more about recovering their losses

VCEL : 35.20 (-5.40%)
Vericel to Report Second-Quarter 2021 Financial Results on August 4, 2021

CAMBRIDGE, Mass., July 21, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the following...

VCEL : 35.20 (-5.40%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Vericel Corporation is focused on developing patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions. The company markets two autologous cell therapy products in the United States: Carticel (R) for the treatment of cartilage defects in the...

See More

Key Turning Points

3rd Resistance Point 40.18
2nd Resistance Point 39.17
1st Resistance Point 37.19
Last Price 35.20
1st Support Level 34.20
2nd Support Level 33.19
3rd Support Level 31.21

See More

52-Week High 68.94
Fibonacci 61.8% 51.89
Fibonacci 50% 46.63
Fibonacci 38.2% 41.36
Last Price 35.20
52-Week Low 24.31

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar